|
|
Volumn 10, Issue 2, 2014, Pages 512-518
|
|
Host genomic HIV restriction factors modulate the response to dendritic cell-based treatment against HIV-1
|
|
Author keywords
DC based immune treatment; HIV vaccine; Host genome and response to vaccine; PARD3B
|
|
Indexed keywords
APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G;
CHEMOKINE RECEPTOR CCR5;
DENDRITIC CELL VACCINE;
GAMMA INTERFERON;
GENOMIC DNA;
HLA C ANTIGEN;
MACROPHAGE INFLAMMATORY PROTEIN 1BETA;
MESSENGER RNA;
RANTES;
STROMAL CELL DERIVED FACTOR 1;
TRANSFORMING GROWTH FACTOR BETA;
TRIPARTITE MOTIF PROTEIN 5;
CARRIER PROTEIN;
MEMBRANE PROTEIN;
PARD3B PROTEIN, HUMAN;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
APOBEC3G GENE;
ARTICLE;
BRAZIL;
CCL4 GENE;
CCL5 GENE;
CCR5 GENE;
CLINICAL ARTICLE;
COHORT ANALYSIS;
CONTROLLED STUDY;
CUL5 GENE;
DISEASE COURSE;
FEMALE;
GENE;
GENE FREQUENCY;
GENETIC RESTRICTION FACTOR;
GENETIC VARIABILITY;
GENOTYPE;
HEREDITY;
HLA C GENE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IFNG GENE;
IMMUNOMODULATION;
IMMUNOTHERAPY;
INFECTION CONTROL;
INFECTION SENSITIVITY;
MALE;
PARD3B GENE;
PHARMACOGENOMICS;
PHASE 1 CLINICAL TRIAL (TOPIC);
PROX1 GENE;
RETROSPECTIVE STUDY;
SDF1 GENE;
SINGLE NUCLEOTIDE POLYMORPHISM;
TREATMENT RESPONSE;
TRIM5 GENE;
VIRUS REPLICATION;
ADULT;
DENDRITIC CELL;
DISEASE PREDISPOSITION;
GENETICS;
HIV INFECTIONS;
IMMUNOLOGY;
PROCEDURES;
TREATMENT OUTCOME;
ADULT;
BRAZIL;
CARRIER PROTEINS;
DENDRITIC CELLS;
DISEASE SUSCEPTIBILITY;
FEMALE;
GENE FREQUENCY;
HIV INFECTIONS;
HIV-1;
HUMANS;
IMMUNOTHERAPY;
MALE;
MEMBRANE PROTEINS;
POLYMORPHISM, SINGLE NUCLEOTIDE;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
|
|
EID: 84896951856
PISSN: 21645515
EISSN: 2164554X
Source Type: Journal
DOI: 10.4161/hv.27125 Document Type: Article |
|
Times cited : (9)
|
|
References (9)
|
